
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
almost 27 years ago
Barriers to Using Cost-Effectiveness Analysis in Managed Cae Decision Makingalmost 27 years ago
Cost of Treating Influenza in Emergency Department and Hospital Settingsalmost 27 years ago
Is Cost-Effectiveness Modeling Useful?


